| |
|
|
Inverness Medical Innovations, Inc. (IMA) is at the forefront of
the convergence of medical diagnostic testing and health
management. IMA is major global developer, manufacturer and
marketer of advanced, pioneering professional and consumer
medical diagnostic products, as well as a leader in specialized
health management services including wellness, disease management,
oncology and women and children's health.
|
| |
|
|
|
| |
 |
|
The Cholestech LDX® System makes it
possible to provide a complete lipid profile with tests for total
cholesterol (TC), HDL & LDL cholesterol, triglycerides, and
glucose (GLU), as well as tests for ALT and AST (for liver enzyme
monitoring), and high sensitivity C-reactive protein (hs-CRP) - and
all done in five minutes per test cassette (seven minutes for
CRP).
|
| |
|
|
|
| |
 |
|
Clearview® professional diagnostic products are
recognized throughout the world for their simplicity, speed,
reliability. The extensive Clearview® portfolio now
offers point-of care-diagnostics in pregnancy and ovulation,
sexually transmitted diseases (STDs), infectious disease,
respiratory disease, gastrointestinal disease and
coagulation/cardiac conditions.
|
| |
|
|
|
| |
 |
|
The globally recognized Determine® line of
rapid in vitro qualitative immunoassays helps detect three potent
sexually transmitted diseases - HIV, hepatitis B and syphilis –
rapidly and reliably.
|
| |
|
|
|
| |
 |
|
The INRatio® monitor is a diagnostic point-of-care
system that provides prothrombin time (PT) and international
normalized ratio (INR) results using fresh capillary whole blood
from a fingerstick. The INRatio® system helps oral
anticoagulation management (by helping maintain the effect of
anticoagulation therapy within the therapeutic range).
|
| |
|
|
|
| |
 |
|
The Inverness Medical TestPack® range provides
rapid point-of-care diagnostic immunoassays for the detection of
hCG and Group A Streptococcus pharyngitis. The on board
controls ("OBC") provide reassurance that results are trustworthy,
reducing the need for external quality control.
|
| |
|
|
|
| |
 |
|
The NMP22® BladderChek® Test is the only
in-office test approved by the FDA as a aid in the
diagnosis of bladder cancer. The NMP22®
BladderChek® Test is a non-invasive assay, performed on
a single urine sample,that detects elevated levels of NMP22
protein.
|
| |
|
|
|
| |
 |
|
The Osteomark® NTx urine and serum ELISA
kits provide a quantitative measurement of cross-linked
N-telopeptides of type I collagen (NTx), a specific biochemical
indicator of bone resorption; higher levels in serum or urine
samples provide evidence of elevated bone resorption, and thus of
osteoporosis risk.
|
| |
|
|
|
| |
 |
|
The Panbio® brand is recognized as a world leader in
tests used in the diagnosis of Flavivirus and other arthropod-borne
viruses. The Company has a history of market leadership in response
to diseases that afflict millions of people and was first to market
with diagnostics for Dengue fever, Ross River fever and West Nile
encephalitis.
|
| |
|
|
|
| |
 |
|
The SureStep™ brand offers point-of-care testing options for
pregnancy, ovulation, drugs of abuse and infectious diseases. All
the tests are simple to perform and provide accurate results in a
matter of minutes.
|
| |
|
|
|
| |
 |
|
The portfolio of TechLab® products includes
rapid non-invasive intestinal diagnostics tests in the areas of
intestinal inflammation, antibiotic-associated diarrhoea and
parasitology.
|
| |
|
|
|
| |
 |
|
The Triage® System includes cardiovascular tools to
aid in the diagnosis and assessment of heart failure and in risk
stratification in acute coronary syndromes and heart failure, aid
in diagnosis of acute myocardial infarction and in the assessment
and evaluation of patients suspected of having disseminated
intravascular coagulation or thromboembolic events including
pulmonary embolism (PE) and DVT. Additionally the
Triage® system has applications for Drugs of Abuse.
|